1. Stocks
    2. /
  2. Exopharm (ASX: EX1)
    3. /

Exopharm (ASX: EX1) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Exopharm Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Exopharm (ASX: EX1)
    Latest News

    ASX bank profit upgrade Red rocket and arrow boosting up a share price chart
    Healthcare Shares

    Why did the Exopharm (ASX:EX1) share price surge 12% today?

    | Lucas Radbourne

    The Exopharm share price is rising today after the company announced positive clinical trial results in humans.

    Read more »

    falling healthcare asx share represented by doctor with head in hands
    Healthcare Shares

    Exopharm (ASX:EX1) share price plunges 17% after animal testing results

    | Lucas Radbourne

    The Exopharm (ASX:EX1) share price is sliding today after the company's osteoarthritis animal treatments showed no effect on the rats…

    Read more »

    EX1 ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Exopharm

    Exopharm Ltd. engages in the development and commercialization of exosomes as therapeutic agents. Its product Exomeres are purified and manufactured using its LEAP Technology. The company was founded by Ian Dixon and Gregor Lichtfuss in 2013 and is headquartered in Melbourne, Australia.

    Profile

    since

    Note